Rankings
▼
Calendar
ALGS FY 2021 Earnings — Aligos Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ALGS
Aligos Therapeutics, Inc.
$45M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
Gross Profit
$4M
100.0% margin
Operating Income
-$128M
-2943.8% margin
Net Income
-$128M
-2944.1% margin
EPS (Diluted)
$-3.22
Cash Flow
Operating Cash Flow
-$116M
Free Cash Flow
-$117M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$235M
Total Liabilities
$51M
Stockholders' Equity
$185M
Cash & Equivalents
$187M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$0
—
Gross Profit
$4M
-$3M
+231.1%
Operating Income
-$128M
-$98M
-31.2%
Net Income
-$128M
-$109M
-18.2%
← Q4 2020
All Quarters
Q1 2021 →